Thymosin Beta-4 at a glance
A fast read for beginners, with evidence strength, route context, safety depth, and community activity surfaced before the deeper sections.
Thymosin Beta-4 (Tβ4) is a naturally occurring 43-amino acid peptide found in virtually all nucleated mammalian cells. It is the most abundant intracellular peptide in mammalian tissue and serves as the primary G-actin sequestering protein, playing a critical role in cell structure, migration, and cytoskeletal organization. TB-500 (the synthetic research compound) is based on the central active region of Thymosin Beta-4 (amino acids 17-23), meaning Tβ4 is the endogenous parent molecule.
Thymosin Beta-4's biological roles are broad: it promotes wound healing and tissue repair, modulates the inflammatory response, supports angiogenesis, and regulates T-cell differentiation in the thymus. It is particularly concentrated at sites of tissue injury, where it serves as a chemotactic signal recruiting stem cells and activating repair programs.
Clinical research on Tβ4 itself (as opposed to TB-500) has advanced in areas including cardiac repair post-myocardial infarction (RegeneRx Biopharmaceuticals trials) and corneal wound healing (eye drops formulation). A Phase 2 trial for dry eye disease using Tβ4 eye drops demonstrated significant symptom improvement. The immune modulation research connects it closely to thymosin alpha-1 in terms of thymic function.
Key Benefits
Saves this peptide to your Watchlist and helps you find new research, news, and questions later.